210
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Oncological repercussions of polycystic ovary syndrome

, , , , &
Pages 708-711 | Received 17 Nov 2009, Accepted 29 Apr 2010, Published online: 08 Jun 2010

References

  • Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181–191.
  • Rotterdam ESHRE/ASRM – Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
  • Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries – a common finding in normal women. Lancet 1988;1:870–872.
  • Futterweit W, Mechanick JI. Polycystic ovarian disease: etiology, diagnosis and treatment. Compr Ther 1988;14:12–20.
  • Carneiro MM, Camargos AF, Aldrighi JM. Síndrome dos ovários policísticos. In: Aldrighi JM, editor. Endocrinologia ginecológica – aspectos contemporâneos. São Paulo: Atheneu; 2006. pp 115–123.
  • Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, McCarthy M. The genetic basis of polycystic ovary syndrome. Hum Reprod 1997;12:2641–2648.
  • Dasgupta S, Reddy BM. Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 2008;54:115–125.
  • Unluturk U, Harmanci A, Kocaefe C, Yildiz BO. The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-γ. PPAR Res 2007;2007:49109.
  • Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998;95:14956–14960.
  • Legro RS, Strauss JF. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 2002;78:569–576.
  • Franks S, McCarthy M. Genetics of ovarian disorders: polycystic ovary syndrome. Rev Endocr Metab Disord 2004;5:69–76.
  • Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001;7:522–525.
  • Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, Menon PA, Leonard AJ, Hardiman P. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21:924–929.
  • Spritzer PM, Morsch DM, Wiltgen D. [Polycystic ovary syndrome associated neoplasms.] Arq Bras Endocrinol Metabol 2005;49:805–810.
  • Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med 2008;26:62–71.
  • Key TJ, Pike MC. The dose–effect relationship between ‘unopposed’ oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205–212.
  • Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 1999;28:247–263.
  • Giudice LC, Dsupin BA, Jin IH, Vu TH, Hoffman AR. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J Clin Endocrinol Metab 1993;76:1115–1122.
  • Rutanen EM. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery. Hum Reprod 2000;15(Suppl 3):173–181.
  • Zhou J, Dsupin BA, Giudice LC, Bondy CA. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1994;79: 1723–1734.
  • Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–3082.
  • Diamanti-Kandarakis E, Baillargeon JP, Iuorno MJ, Jakubowicz DJ, Nestler JE. A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. J Clin Endocrinol Metab 2003;88:1927–1932.
  • World Health Organization. WHOSIS (WHO Statistical Information System). Available from: http://www.who.int/healthinfo/statistics/bodgbddeathdalyestimates.xls
  • National Cancer Institute. Available from: http://www.cancer.gov/cancertopics/types/endometrial
  • Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer. Coordenação de Prevenção e Vigilância de Câncer. Estimativas 2008: Incidência de Câncer no Brasil. Rio de Janeiro: INCA; 2007.
  • Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 2005;105:575–580.
  • Speert H. Carcinoma of the endometrium in young women. Surg Gynaecol Obstet 1949;88:332–336.
  • Dockerty MB, Jackson RL. The Stein-Leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 1957;73:161–173.
  • Chamlian DL, Taylor HB. Endometrial hyperplasia in young women. Obstet Gynecol 1970;36:659–666.
  • Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, Bahamondes L. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women. Aust N Z J Obstet Gynaecol 2008;48:207–213.
  • Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F, Parava M, Vouxinou A, Georgopoulos NA, Kourounis G. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol 2006;127:218–221.
  • Gouveia DA, Bahamondes L, Aldrighi JM, Tamanaha S, Ribeiro AL, Aoki T. [Prevalence of endometrial injury in asymptomatic obese women.] Rev Assoc Med Bras 2007;53:344–348.
  • Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database Syst Rev 2007;(1): CD005552.
  • Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997;79:494–499.
  • Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991;134:818–824.
  • Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403–417.
  • Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long term follow-up. J Clin Epidemiol 1998;51:581–586.
  • Heintz AP, Hacker NF, Lagasse LD. Epidemiology and etiology of ovarian cancer: a review. Obstet Gynecol 1985;66:127–135.
  • Silva-Filho AL, Cândido EB, Noviello MB, Santos-Filho AS, Traiman P, Triginelli SA, Cunha-Melo JR. [Nongynecologic surgery in patients with ovarian cancer.]. Rev Bras Ginecol Obstet 2004;26:411–416.
  • Meirow D, Schenker JG. The link between female infertility and cancer: epidemiology and possible aetiologies. Hum Reprod Update 1996;2:63–75.
  • Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996;88:554–559.
  • Olsen CM, Green AC, Nagle CM, Jordan SJ, Whiteman DC, Bain CJ, Webb PM; Australian cancer study Group (ovarian cancer) and the Australian ovarian cancer study group. Epithelial ovarian cancer: testing the ‘androgens hypothesis'. Endocr Relat Cancer 2008;15:1061–1068.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.